The Structural Formula Of Clindamycin Palmitate Hydrochloride. (Clindamycin Palmitate Hydrochloride 01)
Clindamycin Palmitate Hydrochloride
Product Images NDC 10135-569
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Palmitate Hydrochloride (NDC 10135-569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panelndc 10135-0569-19clindamycinpalmitatehydrochloridefor Oral Solution,usp (pediatric)75 mg* / 5 mL (Clindamycin Palmitate Hydrochloride 02)
Marex Clindamycin Palmitate Hydrochloride is an Oral Solution for Pediatric usage. It comes in a 100mL bottle with reconstitution instructions that require 75mL water. The solution should be stored at 20-25°C and should not be refrigerated after reconstitution. The solution must not be used for injection purposes. The product is manufactured in the USA by Marex Pharmaceuticals and is distributed by the same company. Information on the ingredient strength, date of reconstitution, and other important details are provided.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
